search
Back to results

Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies (FamLit_HF)

Primary Purpose

Medication Adherence, Heart Failure

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
FamLit
Attention Control
Sponsored by
Jia-Rong Wu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Medication Adherence focused on measuring care partner, family, health literacy, teach back

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria - Patient Participants:

  • confirmed diagnosis of heart failure (HF), either systolic or diastolic HF
  • ave suboptimal medication adherence
  • have a care partner (CP) (either spouse, daughter/son, partner, other relative, friend) who is identified by the patient as the person most involved in HF care
  • willingness to have a CP be involved in their medication taking
  • have undergone evaluation of HF and prescribed stable doses of HF medications for at least 3 months
  • live in a setting where the patient is responsible for their ow medication administration
  • willing to use the SimpleMed+ (i.e., an electronic pillbox to measure objective medication adherence)
  • availability by phone

Exclusion Criteria - Patient Participants:

  • cognitive impairment as indicated by having difficulties to understand and give informed consent
  • a recent hospitalization within 3 months of study enrollment
  • co-existing end-stage renal disease or terminal illness such as advanced malignancy, or any other condition with less than 1-year life expectancy
  • psychotic illness
  • current alcohol dependence or other substance abuse
  • inability to speak English or other communication barrier
  • currently or have received any similar self-care intervention recently in the past year

Inclusion Criteria - Care Partners:

  • unpaid family member, friend, partner, or other relation who is involved in the patients' care at least 3 times a week, designated by the patient
  • willing to receive interventions with the patient together
  • 18 years of age or older

Exclusion Criteria - Care Partners:

  • cognitive impairment as indicated by having difficulties to understand and give informed consent
  • coexisting terminal illness
  • non-English speaking or any other communication barrier

Sites / Locations

  • Jia-Rong WuRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Experimental

Experimental

Arm Label

Patients - Attention Only

Care Partners - Attention Only

Patients - FamLit

Care Partners - FamLit

Arm Description

Patients with a confirmed diagnosis of heart failure.

Care partners of patients with a confirmed diagnosis of heart failure.

Patients with a confirmed diagnosis of heart failure.

Care partners of patients with a confirmed diagnosis of heart failure.

Outcomes

Primary Outcome Measures

Medication adherence
Percentage of prescribed doses taken (PDT%) as determined by the electronic SimpleMed+ pillbox. SimpleMed+ will record the date and time that the lid of each compartment is opened and closed. Those data will be used to calculate objective medication adherence: percent prescribed doses taken (PDT%) = (# of doses taken during monitoring period)/(# of prescribed doses during monitoring period) x 100.PDT% ranges from 0-100%.
Self-reported medication adherence.
Adherence will be surveyed the Basel Assessment of Adherence Scale (BAAS), a copyrighted, self-reported scale. The BAAS includes 5 yes-no items and one visual analogue scale (VAS). If participants indicate they have missed a dose (a "yes" response) to any of 5 dichotomous items and <80% on the VAS, they are classified as suboptimally medication adherent.

Secondary Outcome Measures

Patient hospitalization
Percentage of patients hospitalized. HF hospitalizations will be determined by a combination of medical record review and monthly phone interviews with patients and/or care partners to collect data for all encounters.
Quality of life - Minnesota Living with Heart Failure
The 21-item Minnesota Living with Heart Failure (MLHF) questionnaire measures the patient's perceptions of the influence of HF on physical and emotional aspects of life. The items are scored on a Likert scale from 0 (No) to 5 (Very much). The scores of the 21 items will be summed with higher scores of the MLHF indicating worse quality of life.
Positive Affect
Generic quality of life will be assessed using the NeuroQoL Positive Affect and Well-Being short form, which has 9 items and each item is rated on a 5-point Likert scale from 1 (never) to 5 (always); higher scores indicate better quality of life.

Full Information

First Posted
September 16, 2022
Last Updated
May 11, 2023
Sponsor
Jia-Rong Wu
Collaborators
National Institute of Nursing Research (NINR)
search

1. Study Identification

Unique Protocol Identification Number
NCT05548413
Brief Title
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
Acronym
FamLit_HF
Official Title
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies in Patients With Heart Failure
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 4, 2023 (Actual)
Primary Completion Date
June 2027 (Anticipated)
Study Completion Date
December 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jia-Rong Wu
Collaborators
National Institute of Nursing Research (NINR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partners to help them work together and build skills to overcome their individual barriers to adherence in order to 1) improve and sustain patient medication adherence; 2) reduce hospitalization; 3) improve quality of life. If effective, this intervention will support long-term medication adherence, thus reducing hospitalizations related to heart failure and quality of life.
Detailed Description
Medication adherence is thought by many providers and researchers to be the most important self-care behavior, yet it is also the most problematic. Poor medication adherence can cause poor quality of life (QoL), hospitalization, and death. In the United States, approximately 125,000 deaths per year are due to poor medication adherence and up to 50% of heart failure (HF) patients are re-hospitalized within 6 months of a previous HF exacerbation and one of the most common causes is poor medication adherence. Lifelong and usually complex medication regimens are needed for patients with HF, yet 40-60% of HF patients have suboptimal medication adherence. Health literacy plays a significant role in suboptimal medication adherence. Support by a care partner (CP; usually a family member) can improve adherence and reduce hospitalizations. Although some interventions have improved HF patients' adherence, improvements were small, and effects were not sustained. To enhance and sustain intervention effects, an approach that is literacy-sensitive and incorporates social support will be used. Using easy-to-understand language for patients and CPs, investigators will test an interactive, behavioral, family-focused and literacy-sensitive (FamLit) intervention delivered by nurses, incorporating evidence-based, multi-components (e.g., teach-back, coaching, role-playing, goal setting) to engage both patients and CPs in improving and sustaining medication adherence and health outcomes. A randomized controlled trial will be conducted to evaluate the efficacy of FamLit intervention on medication adherence, hospitalization, death, and QoL. 164 dyads of patients and their primary CPs (patients-CPs) will be randomly assigned to either the FamLit intervention or an attention-control group. Both groups will have an in-person session (delivered on the day of a clinic appointment for regular follow-up) one month after baseline and phone boosters every other week for up to 3 months. FamLit group sessions will focus on improving medication adherence, and control group sessions will focus on general health issues. Aims are to: 1) test the efficacy of the FamLit intervention compared to an attention control group on outcomes (i.e., primary: medication adherence, and secondary: a) HF hospitalization or all-cause death, b) QoL over 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Medication Adherence, Heart Failure
Keywords
care partner, family, health literacy, teach back

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
328 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients - Attention Only
Arm Type
Active Comparator
Arm Description
Patients with a confirmed diagnosis of heart failure.
Arm Title
Care Partners - Attention Only
Arm Type
Active Comparator
Arm Description
Care partners of patients with a confirmed diagnosis of heart failure.
Arm Title
Patients - FamLit
Arm Type
Experimental
Arm Description
Patients with a confirmed diagnosis of heart failure.
Arm Title
Care Partners - FamLit
Arm Type
Experimental
Arm Description
Care partners of patients with a confirmed diagnosis of heart failure.
Intervention Type
Behavioral
Intervention Name(s)
FamLit
Intervention Description
The FamLit (Family-focused and Literacy-sensitive strategy) is an interactive, multi-component intervention supported by the FamLit intervention Guide, including both spoken and printed materials written at a 4th-grade reading level for HF patients and their primary CPs.Three constructs guide the intervention, based on the Theory of Planned Behavior (TPB): 1) develop patient and CP positive attitudes through HF instruction and teach-back; 2) form positive subjective norms through coaching to improve patient and CP communication, support, and teamwork; and 3) increase perceived behavioral control through coaching and role-playing to empower patients and CPs to overcome individual barriers to adherence. This intervention also includes use of the SimpleMed+ electronic pillbox.
Intervention Type
Behavioral
Intervention Name(s)
Attention Control
Intervention Description
Participants in this group will talk with an interventionist to discuss general health. This intervention also includes use of the SimpleMed+ electronic pillbox.
Primary Outcome Measure Information:
Title
Medication adherence
Description
Percentage of prescribed doses taken (PDT%) as determined by the electronic SimpleMed+ pillbox. SimpleMed+ will record the date and time that the lid of each compartment is opened and closed. Those data will be used to calculate objective medication adherence: percent prescribed doses taken (PDT%) = (# of doses taken during monitoring period)/(# of prescribed doses during monitoring period) x 100.PDT% ranges from 0-100%.
Time Frame
12 months
Title
Self-reported medication adherence.
Description
Adherence will be surveyed the Basel Assessment of Adherence Scale (BAAS), a copyrighted, self-reported scale. The BAAS includes 5 yes-no items and one visual analogue scale (VAS). If participants indicate they have missed a dose (a "yes" response) to any of 5 dichotomous items and <80% on the VAS, they are classified as suboptimally medication adherent.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Patient hospitalization
Description
Percentage of patients hospitalized. HF hospitalizations will be determined by a combination of medical record review and monthly phone interviews with patients and/or care partners to collect data for all encounters.
Time Frame
12 months
Title
Quality of life - Minnesota Living with Heart Failure
Description
The 21-item Minnesota Living with Heart Failure (MLHF) questionnaire measures the patient's perceptions of the influence of HF on physical and emotional aspects of life. The items are scored on a Likert scale from 0 (No) to 5 (Very much). The scores of the 21 items will be summed with higher scores of the MLHF indicating worse quality of life.
Time Frame
12 months
Title
Positive Affect
Description
Generic quality of life will be assessed using the NeuroQoL Positive Affect and Well-Being short form, which has 9 items and each item is rated on a 5-point Likert scale from 1 (never) to 5 (always); higher scores indicate better quality of life.
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Caregiver Burden
Description
The Zarit Caregiver Burden Interview (ZBI) measures caregiver burden. The ZBI has 12 items and each item is rated on a 5-point Likert scale from 0 (never) to 4 (always); higher scores indicate higher caregiver burden.
Time Frame
12 months
Title
Numeracy health literacy
Description
The Newest Vital Sign (NVS) will be used to assess numeracy. Participants will be given a nutritional label and be asked 6 questions about its content. Participants will get one point for each question they are correct. Participants will be scored on the number of questions they get correct, higher scores indicate better numeracy health literacy.
Time Frame
12 months
Title
Health Literacy
Description
The 36-item Short Test of Functional Health Literacy in Adults (S-TOFHLA),which has 36-items. Participants will be scored on the number of items they got correct (one point for each correct item), higher scores indicate better health literacy. Patients and CPs will be categorized as low (0-22) or high (23-36) health literacy.
Time Frame
12 months
Title
Medication Adherence Scale
Description
The psychometrically sound Medication Adherence Scale (MAS) with 3 subscales to measure constructs of the Theory of Planned Behavior. The Attitude subscale has 7 items on a Likert scale from 0 (strongly disagree) to 10 (strongly agree), higher scores indicate better attitudes. The Subjective Norm subscale has 4 items on a Likert scale from 1 (strongly disagree) to 5 (strongly agree), higher scores indicate more positive subjective norm. The Perceived Behavioral Control subscale has 12 items on a Likert scale from 0 (never being a cause) to 10 (very important cause), higher scores indicate more barriers.
Time Frame
12 months
Title
Communication
Description
Communication will be measured using the 6-item Family Assessment Device (FAD) Communication subscale. Each survey item is scored on a Likert scale from 1 (strongly disagree) to 4 (strongly agree). The FAD is scored by adding the responses (1-4) of the 6 items and dividing by 6. Higher scores indicate worse levels of family functioning on communication.
Time Frame
12 months
Title
Social Support
Description
We will assess social support using the 8-item, modified Medical Outcome Study Social Support Scale (mMOS-SS). Each survey item is scored on a Likert scale from 1 (none of the time) to 5 (all of the time). The total sum of the items is then used to calculate a mMOS-SS score with values between 0 and 100, with higher scores indicating better social support.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria - Patient Participants: confirmed diagnosis of heart failure (HF), either systolic or diastolic HF ave suboptimal medication adherence have a care partner (CP) (either spouse, daughter/son, partner, other relative, friend) who is identified by the patient as the person most involved in HF care willingness to have a CP be involved in their medication taking have undergone evaluation of HF and prescribed stable doses of HF medications for at least 3 months live in a setting where the patient is responsible for their ow medication administration willing to use the SimpleMed+ (i.e., an electronic pillbox to measure objective medication adherence) availability by phone Exclusion Criteria - Patient Participants: cognitive impairment as indicated by having difficulties to understand and give informed consent a recent hospitalization within 3 months of study enrollment co-existing end-stage renal disease or terminal illness such as advanced malignancy, or any other condition with less than 1-year life expectancy psychotic illness current alcohol dependence or other substance abuse inability to speak English or other communication barrier currently or have received any similar self-care intervention recently in the past year Inclusion Criteria - Care Partners: unpaid family member, friend, partner, or other relation who is involved in the patients' care at least 3 times a week, designated by the patient willing to receive interventions with the patient together 18 years of age or older Exclusion Criteria - Care Partners: cognitive impairment as indicated by having difficulties to understand and give informed consent coexisting terminal illness non-English speaking or any other communication barrier
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jia-Rong Wu, PhD
Phone
8593234712
Email
jiarong.wu2@uky.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jia-Rong Wu
Organizational Affiliation
University of Kentucky
Official's Role
Principal Investigator
Facility Information:
Facility Name
Jia-Rong Wu
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40536
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jia-Rong Wu, PhD
Phone
859-323-4712
Email
jiarong.wu2@uky.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies

We'll reach out to this number within 24 hrs